Higher concentrations of AMBP and PRDX2 markers were found in the lung cancer group compared to the control group (with a fold change (FC) of 3.4 and 2.0, respectively), whereas PARK7 concentration was lower (FC = 0.49). The gene discussed is PRDX2; the disease is lung cancer.